Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Hi, what are you looking for?
Jewish Business News
All posts tagged "Heather Bresch"
Business
Teva says it will seek ‘further appellate review’
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.
Business
In the three way takeover battle Mylan is getting nervous.
Business
Three Way Takeover Battle: believes their offer will win approval from Perrigo stockholders.
Business
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Business
John Paulson's hedge fund has increased its holdings in Mylan NV to 4.5%.
empty
– The decision maintains exclusivity for Copaxone until May 24, 2014. – Copaxone/ source : dynamik3d.ca – On Friday, the US Court of Appeals for...